MedPath

Paracetamol and its Influence on the Opioid Requirement in Sufficient Pain Management in the ED

Conditions
Opioid use, pain
Registration Number
NL-OMON22636
Lead Sponsor
Academic Medical Center (AMC), Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
168
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

- patients 18 years or older presenting to the ED in the AMC

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

- hepatic dysfunction

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study endpoint is the opioid requirement in Morphine Equivalent Units (MEU) between individual subjects who received additional paracetamol and those who did not.
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is the NRS measured an hour after administration of the opioid and at discharge, between individual subjects who received additional paracetamol at the ED and those who did not.
© Copyright 2025. All Rights Reserved by MedPath